SK280313B6 - N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov - Google Patents

N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov Download PDF

Info

Publication number
SK280313B6
SK280313B6 SK2047-90A SK204790A SK280313B6 SK 280313 B6 SK280313 B6 SK 280313B6 SK 204790 A SK204790 A SK 204790A SK 280313 B6 SK280313 B6 SK 280313B6
Authority
SK
Slovakia
Prior art keywords
formula
fluoro
compound
purine
derivatives
Prior art date
Application number
SK2047-90A
Other languages
English (en)
Slovak (sk)
Inventor
Anton�N Hol�
Jind�Ich Jind�Ich
Jan Balzarini
Clercq Erik De
Original Assignee
�Stav Organick� Chemie A Biochemie Av �R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �Stav Organick� Chemie A Biochemie Av �R filed Critical �Stav Organick� Chemie A Biochemie Av �R
Publication of SK280313B6 publication Critical patent/SK280313B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK2047-90A 1990-04-24 1990-04-24 N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov SK280313B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS902047A CZ285420B6 (cs) 1990-04-24 1990-04-24 N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití

Publications (1)

Publication Number Publication Date
SK280313B6 true SK280313B6 (sk) 1999-11-08

Family

ID=5356430

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2047-90A SK280313B6 (sk) 1990-04-24 1990-04-24 N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov

Country Status (15)

Country Link
US (1) US5733896A (cs)
EP (1) EP0454427B1 (cs)
JP (1) JP2937532B2 (cs)
AT (1) ATE131171T1 (cs)
AU (1) AU7533091A (cs)
CA (1) CA2040982C (cs)
CZ (1) CZ285420B6 (cs)
DE (1) DE69115108T2 (cs)
FI (1) FI911980L (cs)
IE (1) IE911356A1 (cs)
IL (1) IL98110A0 (cs)
NO (1) NO911600L (cs)
PT (1) PT97478B (cs)
SK (1) SK280313B6 (cs)
ZA (1) ZA913033B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284678B6 (cs) * 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6339151B1 (en) 1998-01-23 2002-01-15 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
JP2003525866A (ja) 1999-07-22 2003-09-02 ニューバイオティックス インコーポレイテッド 治療抵抗性腫瘍を処置するための方法
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
WO2001044257A1 (en) * 1999-12-17 2001-06-21 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
EA004926B1 (ru) 2000-07-21 2004-10-28 Джилид Сайэнс, Инк. Пролекарственные соединения фосфонатных аналогов нуклеотидов (варианты), способ их получения, способ скрининга для их идентификации и содержащая их композиция, способ антивирусной терапии или профилактики
US6747132B2 (en) 2000-11-29 2004-06-08 Apex Biosciences, Inc. Methods for the synthesis of a modified hemoglobin solution
IL159494A0 (en) 2001-06-29 2004-06-01 Acad Of Science Czech Republic 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
JP5280631B2 (ja) 2003-06-16 2013-09-04 インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー， アカデミー オブ サイエンシズ オブ ザ チェコ リパブリック 抗ウイルスヌクレオチド類似物としてのホスホネート基を有するピリミジン化合物
WO2006066074A2 (en) * 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
US20090156545A1 (en) * 2005-04-01 2009-06-18 Hostetler Karl Y Substituted Phosphate Esters of Nucleoside Phosphonates
CA2616314A1 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of hiv
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
KR20110077004A (ko) * 2008-10-24 2011-07-06 글락소스미스클라인 바이오로지칼즈 에스.에이. 지질화된 이미다조퀴놀린 유도체
EP2794624B1 (en) 2011-12-22 2019-05-15 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
LT2970346T (lt) 2013-03-15 2018-11-26 The Regents Of The University Of California Acikliniai nukleozido fosfonato diesteriai
AU2015317972B2 (en) 2014-09-15 2019-10-17 The Regents Of The University Of California Nucleotide analogs
EP3350191B9 (en) 2015-09-15 2021-12-22 The Regents of the University of California Nucleotide analogs
JP2025526212A (ja) 2022-07-21 2025-08-13 アンティバ バイオサイエンシズ インコーポレイテッド Ｈｐｖ感染症及びｈｐｖ誘発性新生物の治療用の組成物及び剤形

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
AU8092587A (en) * 1986-11-18 1988-05-19 Bristol-Myers Squibb Company Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
US4808419A (en) * 1987-02-02 1989-02-28 Hsu Edward J Automated method for a semi-solid fermentation used in the production of ancient quality rice vinegar and/or rice wine
ATE98249T1 (de) * 1988-04-19 1993-12-15 Merrell Dow Pharma Phosphonoalkylpurin-derivate.
EP0338168A1 (en) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurine derivatives
JPH0296589A (ja) * 1988-09-30 1990-04-09 Asahi Glass Co Ltd ヌクレオシド類

Also Published As

Publication number Publication date
EP0454427B1 (en) 1995-12-06
FI911980A7 (fi) 1991-10-25
IL98110A0 (en) 1992-06-21
EP0454427A1 (en) 1991-10-30
CS9002047A2 (en) 1991-11-12
IE911356A1 (en) 1991-11-06
PT97478B (pt) 1998-08-31
CZ285420B6 (cs) 1999-08-11
FI911980A0 (fi) 1991-04-24
US5733896A (en) 1998-03-31
FI911980L (fi) 1991-10-25
NO911600L (no) 1991-10-25
JPH06206888A (ja) 1994-07-26
DE69115108T2 (de) 1996-07-04
DE69115108D1 (de) 1996-01-18
PT97478A (pt) 1992-01-31
AU7533091A (en) 1991-11-07
JP2937532B2 (ja) 1999-08-23
CA2040982C (en) 2001-12-04
ATE131171T1 (de) 1995-12-15
NO911600D0 (no) 1991-04-23
CA2040982A1 (en) 1991-10-25
ZA913033B (en) 1992-01-29

Similar Documents

Publication Publication Date Title
SK280313B6 (sk) N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
Verheggen et al. Synthesis and antiherpes virus activity of 1, 5-anhydrohexitol nucleosides
Holý et al. Structure− antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy) ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base
Holı et al. Synthesis and cytostatic activity of N-[2-(phosphonomethoxy) alkyl] derivatives of N 6-substituted adenines, 2, 6-diaminopurines and related compounds
Prisbe et al. Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1, 3-dihydroxy-2-propoxy) methyl] guanine
JPH0822866B2 (ja) プリンおよびピリミジン塩基のｎ−ホスホニルメトキシアルキル誘導体
AU2011282241B2 (en) Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
EP0272446B1 (en) Novel antiviral agents
US5047533A (en) Acyclic purine phosphonate nucleotide analogs
Yu et al. Synthesis and antiviral activity of methyl derivatives of 9-[2-(phosphonomethoxy) ethyl] guanine
Meier et al. Chemistry and anti-herpes simplex virus type 1 evaluation of cyclo Sal-nucleotides of acyclic nucleoside analogues
Kim et al. A new class of acyclic phosphonate nucleotide analogs: Phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents
Liboska et al. Carbocyclic phosphonate-based nucleotide analogs related to PMEA. I. Racemic trans-configured derivatives
Raju et al. Synthesis and biological properties of purine and pyrimidine 5'-deoxy-5'-(dihydroxyphosphinyl)-. beta.-D-ribofuranosyl analogs of AMP, GMP, IMP, and CMP
Shimizu et al. The synthesis and biological properties of some aryl bis (nucleosid-5′-yl) phosphates using nucleosides with proven anti-HIV activity
Zhou et al. Synthesis of aminopropyl phosphonate nucleosides with purine and pyrimidine bases
Liu et al. Synthesis and antiviral evaluation of base-modified deoxythreosyl nucleoside phosphonates
JPH05105696A (ja) ジデオキシヌクレオシド及びホスホノホルミツク酸の複合体
Krečmerová et al. Synthesis of N 9-and N 7-[2-Hydroxy-3-(phosphonomethoxy) propyl] Derivatives of N 6-Substituted Adenines, 2, 6-Diaminopurines and Related Compounds
Točík et al. Electrophile-promoted addition of hydroxymethylphosphonate to 4′, 5′-didehydronucleosides: A way to novel isosteric analogues of 5′-nucleotides
Otmar et al. An alternative synthesis of HPMPC and HPMPA diphosphoryl derivatives
Vrbkova et al. Bifunctional acyclic nucleoside phosphonates: 2. Symmetrical 2-{[bis (phosphono) methoxy] methyl} ethyl derivatives of purines and pyrimidines
Martin et al. Synthesis of 4′-(Hydroxymethyl) Guanosine and a Phosphonate Analogue of Guanylic Acid
Shen et al. Synthesis and Conformation of Novel 3'-Branched Threosyl-5'-Deoxyphosphonic Acid Nucleoside Analogues
Franchetti et al. Synthesis of Unsaturated Analogues of 9-[2 (Phosphono-Methoxy) Propyl] Guanine as Antiviral Agents

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20100424